Recent advancements in the targeted delivery of Gemcitabine: Harnessing nanomedicine for enhanced cancer therapy
Gemcitabine (GEM) is a chemotherapeutic drug widely used for treating pancreatic cancer and other cancers. Despite its efficacy, GEM is associated with adverse side effects and tumor resistance, hampering its therapeutic outcomes. To address these challenges, innovative strategies have emerged to en...
Main Authors: | Mehrab Pourmadadi, Ali Aslani, Dilawar Hassan, Ayesha Sani, Abbas Rahdar, Dora I. Medina, Majid Abdouss, Luiz Fernando Romanholo Ferreira |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | OpenNano |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352952023000567 |
Similar Items
-
Nanoparticle-Based Drug Delivery Systems Enhance Treatment of Cognitive Defects
by: Wilar G, et al.
Published: (2024-11-01) -
Nanomedicine for Treating Diabetic Retinopathy Vascular Degeneration
by: Tatiana Borodina, et al.
Published: (2021-11-01) -
Nano-interventions for the drug delivery of docetaxel to cancer cells
by: Nishtha Chaurawal, et al.
Published: (2023-06-01) -
Recent Advances in Subunit Vaccine Carriers
by: Abhishek Vartak, et al.
Published: (2016-04-01) -
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
by: Amanda Cano, et al.
Published: (2021-04-01)